Key facts
| Price (PPV) | 114.30 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | losartanhydrochlorothiazide |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09DA01 |
| Manufacturer | BOTTU S.A. |
| Presentation | Boîte de 30 |
| Nature | Médicament |
| Hospital price | 71.50 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de l’hypertension artérielle essentielle chez les patients dont la pression artérielle n’est pas suffisamment contrôlée par le losartan ou l’hydrochlorothiazide en monothérapie.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
In Morocco, 9 other products contain the same active substance as Diprezar 50 mg / 12.5 mg (Losartan | Hydrochlorothiazide), at the same strength and in the same dosage form. For the same pack size (Boîte de 30), the cheapest is Ancine Plus 50 mg / 12.5 mg (NOVOPHARMA) at 64.20 MAD, i.e. 44 % less than Diprezar 50 mg / 12.5 mg (114.30 MAD). The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Ancine Plus 50 mg / 12.5 mg | NOVOPHARMA | Boite de 30 | 64.20 MAD | 2.14 / unit | −44 % |
| Co Medzar 50 mg / 12.5 mg | POLYMEDIC | Boite de 30 | 106.70 MAD | 3.56 / unit | −7 % |
| Co-Anginib 50 mg / 12.5 mg | PHI | Boite de 30 | 114.30 MAD | 3.81 / unit | — |
| Losartan / Hydrochlorothiazide GT 50 mg / 12.5 mg | ATLAS PHARM | Boite de 30 | 114.30 MAD | 3.81 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Bi-Hyplos 50 mg / 12.5 mg | SPIMACO | Boite de 14 | 60.60 MAD | 4.33 / unit |
| Co-Tanzaar 50 mg / 12.5 mg | AFRIC-PHAR | Boite de 14 | 60.60 MAD | 4.33 / unit |
| Bi-Hyplos 50 mg / 12.5 mg | SPIMACO | Boite de 28 | 90 MAD | 3.21 / unit |
| Co-Rosar 50 mg / 12.5 mg | PHARMIS | Boite de 28 | 101 MAD | 3.61 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Diprezar 50 mg / 12.5 mg
Diprezar 50 mg / 12.5 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by BOTTU S.A. and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Diprezar 50 mg / 12.5 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Diprezar 50 mg / 12.5 mg
Answers to common questions from Moroccan patients about this drug.